Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.25 is 12% above its 5-year average of -0.28, near the high end of its 5-year range (-0.40–-0.20).
16.28% below its 12-month average of -0.22.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.07.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:47:29.532Z. Historical observations retain their original dates. Historical series through 2021-03-18.
EARNINGS PER SHARE (EPS)
-0.25
EARNINGS PER SHARE (EPS) AVG TTM
-0.22
EARNINGS PER SHARE (EPS) AVG 3Y
-0.27
EARNINGS PER SHARE (EPS) AVG 5Y
-0.28
EARNINGS PER SHARE (EPS) AVG 10Y
-27.32
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.28%
CURRENT VS 3Y AVG
+8.26%
CURRENT VS 5Y AVG
+11.76%
CURRENT VS 10Y AVG
+99.09%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Ocugen, Inc.
Market Cap
$356.07M
Earnings Per Share (EPS)
-0.25
TTM Avg
-0.22
3Y Avg
-0.27
5Y Avg
-0.28
Market Cap
$356.40M
Earnings Per Share (EPS)
-0.14
TTM Avg
-0.19
3Y Avg
-0.48
5Y Avg
-0.56
Market Cap
$356.92M
Earnings Per Share (EPS)
0.36
TTM Avg
0.33
3Y Avg
0.27
5Y Avg
0.36
Market Cap
$354.94M
Earnings Per Share (EPS)
-3.31
TTM Avg
-3.43
3Y Avg
-2.65
5Y Avg
-2.61
Market Cap
$357.37M
Earnings Per Share (EPS)
-2.41
TTM Avg
-4.66
3Y Avg
-5.40
5Y Avg
-4.56
Market Cap
$353.90M
Earnings Per Share (EPS)
-0.99
TTM Avg
-1.39
3Y Avg
-1.39
5Y Avg
-0.93
Market Cap
$353.52M
Earnings Per Share (EPS)
-0.29
TTM Avg
-0.18
3Y Avg
-0.18
5Y Avg
-0.18
Market Cap
$358.93M
Earnings Per Share (EPS)
1.48
TTM Avg
1.49
3Y Avg
2.03
5Y Avg
3.82
Market Cap
$348.23M
Earnings Per Share (EPS)
-0.92
TTM Avg
-2.05
3Y Avg
-3.17
5Y Avg
-3.94
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ocugen, Inc. (OCGN) | $356.07M | -0.25 | -0.22 | -0.27 | -0.28 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $356.40M | -0.14 | -0.19 | -0.48 | -0.56 |
| Viemed Healthcare, Inc. (VMD)vs › | $356.92M | 0.36 | 0.33 | 0.27 | 0.36 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $354.94M | -3.31 | -3.43 | -2.65 | -2.61 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $357.37M | -2.41 | -4.66 | -5.40 | -4.56 |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $353.90M | -0.99 | -1.39 | -1.39 | -0.93 |
| Turn Therapeutics Inc. (TTRX)vs › | $353.52M | -0.29 | -0.18 | -0.18 | -0.18 |
| Embecta Corp. (EMBC)vs › | $358.93M | 1.48 | 1.49 | 2.03 | 3.82 |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.23M | -0.92 | -2.05 | -3.17 | -3.94 |
| Opus Genetics, Inc. (IRD)vs › | $365.67M | N/A | -1.30 | -1.38 | -1.95 |
Trailing EPS (TTM)
$-0.25
Forward EPS (Est.)
$-0.26
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.23 |
| 2024-12-31 | -0.20 |
| 2023-12-31 | -0.26 |
| 2022-12-31 | -0.40 |
| 2021-12-31 | -0.30 |
| 2020-12-31 | -0.31 |
| 2019-12-31 | -1.53 |
| 2018-12-31 | -13.98 |
| 2017-12-31 | -69.91 |
| 2016-12-31 | -68.21 |
| 2015-12-31 | -145.22 |
| 2014-12-31 | -891.47 |
| 2013-12-31 | -120.93 |
| 2012-12-31 | -79.65 |
